de Vor Inge C, van der Meulen Pomme M, Bekker Vincent, Verhard Els M, Breuning Martijn H, Harnisch Esther, van Tol Maarten J D, Wieringa Jantien W, van de Vosse Esther, Bredius Robbert G M
Department of Pediatrics, Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands.
Department of Pediatrics, Medical Center Haaglanden, Lijnbaan 32, 2512 VA, The Hague, The Netherlands.
J Clin Immunol. 2016 Apr;36(3):195-203. doi: 10.1007/s10875-016-0244-y. Epub 2016 Mar 1.
Complete interferon-γ receptor 1 (IFN-γR1) deficiency is a primary immunodeficiency causing predisposition to severe infection due to intracellular pathogens. Only 36 cases have been reported worldwide. The purpose of this article is to describe a large novel deletion found in 3 related cases, which resulted in the complete removal of the IFNGR1 gene.
Whole blood from three patients was stimulated with lipopolysaccharide (LPS) and IFN-γ to determine production of tumor necrosis factor (TNF), interleukin-12 p40 (IL-12p40) and IL-10. Expression of IFN-γR1 on the cell membrane of patients' monocytes was assessed using flow cytometry. IFNGR1 transcript was analyzed in RNA and the gene and adjacent regions were analyzed in DNA. Finally, IL22RA2 transcript levels were analyzed in whole blood cells and dendritic cells.
There was no expression of the IFN-γR1 on the monocytes. Consistent with this finding, there was no IFN-γ response in the whole blood assay as measured by effect on LPS-induced IL-12p40, TNF and IL-10 production. A 119.227 nt homozygous deletion on chromosome 6q23.3 was identified, removing the IFNGR1 gene completely and ending 117 nt upstream of the transcription start of the IL22RA2 gene. Transcript levels of IL22RA2 were similar in patient and control.
We identified the first large genomic deletion of IFNGR1 causing complete IFN-γR1 deficiency. Despite the deletion ending very close to the IL22RA2 gene, it does not appear to affect IL22RA2 transcription and, therefore, may not have any additional clinical consequence.
完全性γ干扰素受体1(IFN-γR1)缺陷是一种原发性免疫缺陷病,可导致因细胞内病原体感染而引发严重感染的易感性。全球仅报道了36例。本文旨在描述在3例相关病例中发现的一个大型新缺失,该缺失导致IFNGR1基因完全缺失。
用脂多糖(LPS)和γ干扰素刺激3例患者的全血,以测定肿瘤坏死因子(TNF)、白细胞介素-12 p40(IL-12p40)和IL-10的产生。使用流式细胞术评估患者单核细胞膜上IFN-γR1的表达。对RNA中的IFNGR1转录本进行分析,并对DNA中的基因及相邻区域进行分析。最后,对全血细胞和树突状细胞中的IL22RA2转录本水平进行分析。
单核细胞上未检测到IFN-γR1的表达。与该发现一致,在全血检测中,通过对LPS诱导的IL-12p40、TNF和IL-10产生的影响来衡量,未观察到γ干扰素反应。在6号染色体q23.3处鉴定出一个119227 nt的纯合缺失,该缺失完全去除了IFNGR1基因,并在IL22RA2基因转录起始点上游117 nt处终止。患者和对照中IL22RA2的转录本水平相似。
我们鉴定出首个导致完全性IFN-γR1缺陷的IFNGR1大型基因组缺失。尽管该缺失在非常接近IL22RA2基因处终止,但似乎并未影响IL22RA2的转录,因此可能不会产生任何额外的临床后果。